Racial Disparities in Minimally Invasive Benign Hysterectomy

Overview

Journal JSLS

Specialty General Surgery

Date 2025 Jan 3

PMID 39749229

Authors

Kamran Hessami

Marie-Claire Leaf

Jinxiao Liang

Adi Katz

Frank Chervenak

Abdelrahman AlAshqar

Mostafa A Borahay

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Racial and ethnic disparities in access to minimally invasive surgery (MIS) and the rate of surgical complications in minority groups remain profoundly underinvestigated. This meta-analysis aims to compare the rate of MIS utilization for benign hysterectomy as well as the surgical morbidity among racial and ethnic minority patients in the United States.

Methods: Studies comparing utilization rate of MIS for benign hysterectomy among non-Hispanic white, Black, and Hispanic populations were considered eligible. The primary outcome was the rate of MIS according to race. The secondary outcome was surgical morbidity risk (Clavien-Dindo Classification) according to hysterectomy route and race. Random-effect model meta-analysis pooled unadjusted and adjusted odds ratios (ORs) with 95% confidence intervals (CIs).

Results: Thirteen studies were eligible, with a total of 1,123,851 patients undergoing benign hysterectomy, of whom 817,209 were white, 187,488 Black, and 119,154 Hispanic. Black and Hispanic patients were less likely to undergo MIS compared to white patients (Black: OR 0.44 [95% CI 0.39-0.49] and Hispanic: OR 0.65 [95% CI 0.59-0.71]). After pooling adjusted estimates, the rate of MIS use remained significantly lower in nonwhite populations. Nonwhite patients were more likely to develop surgical complications after hysterectomy in either MIS (OR 1.32 [95% CI: 1.15-1.52]) or open hysterectomy (OR 1.56 [95% CI: 1.40-1.73]).

Conclusion: Racial and ethnic disparities in MIS utilization for benign hysterectomy are strikingly apparent in the United States, with nonwhite patients often demonstrating lower access to MIS utilization and higher rates of surgical morbidity than white patients.

References

Smith A, AlAshqar A, Chaves K, Borahay M . Association of demographic, clinical, and hospital-related factors with use of robotic hysterectomy for benign indications: A national database study. Int J Med Robot. 2020; 16(4):e2107. PMC: 9206512. DOI: 10.1002/rcs.2107. View

Patel P, Lee J, Rodriguez A, Borahay M, Snyder R, Hankins G . Disparities in use of laparoscopic hysterectomies: a nationwide analysis. J Minim Invasive Gynecol. 2013; 21(2):223-7. PMC: 4321735. DOI: 10.1016/j.jmig.2013.08.709. View

Schneyer R, Greene N, Wright K, Truong M, Molina A, Tran K . The Impact of Race and Ethnicity on Use of Minimally Invasive Surgery for Myomas. J Minim Invasive Gynecol. 2022; 29(11):1241-1247. DOI: 10.1016/j.jmig.2022.06.025. View

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

Alexander A, Strohl A, Rieder S, Holl J, Barber E . Examining Disparities in Route of Surgery and Postoperative Complications in Black Race and Hysterectomy. Obstet Gynecol. 2018; 133(1):6-12. PMC: 6326082. DOI: 10.1097/AOG.0000000000002990. View

Abenhaim H, Azziz R, Hu J, Bartolucci A, Tulandi T . Socioeconomic and racial predictors of undergoing laparoscopic hysterectomy for selected benign diseases: analysis of 341487 hysterectomies. J Minim Invasive Gynecol. 2008; 15(1):11-5. DOI: 10.1016/j.jmig.2007.07.014. View

Catherino W, Eltoukhi H, Al-Hendy A . Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma. Semin Reprod Med. 2013; 31(5):370-9. PMC: 4170830. DOI: 10.1055/s-0033-1348896. View

. Committee Opinion No. 701 Summary: Choosing The Route Of Hysterectomy For Benign Disease. Obstet Gynecol. 2017; 129(6):1149-1150. DOI: 10.1097/AOG.0000000000002108. View

Cohen S, Vitonis A, Einarsson J . Updated hysterectomy surveillance and factors associated with minimally invasive hysterectomy. JSLS. 2014; 18(3). PMC: 4208898. DOI: 10.4293/JSLS.2014.00096. View

10.

Pollack L, Olsen M, Gehlert S, Chang S, Lowder J . Racial/Ethnic Disparities/Differences in Hysterectomy Route in Women Likely Eligible for Minimally Invasive Surgery. J Minim Invasive Gynecol. 2019; 27(5):1167-1177.e2. PMC: 7062558. DOI: 10.1016/j.jmig.2019.09.003. View

11.

Lee J, Jennings K, Borahay M, Rodriguez A, Kilic G, Snyder R . Trends in the national distribution of laparoscopic hysterectomies from 2003 to 2010. J Minim Invasive Gynecol. 2014; 21(4):656-61. PMC: 4318237. DOI: 10.1016/j.jmig.2014.01.012. View

12.

Cooper M, Hutfless S, Segev D, Ibrahim A, Lyu H, Makary M . Hospital level under-utilization of minimally invasive surgery in the United States: retrospective review. BMJ. 2014; 349:g4198. PMC: 4087169. DOI: 10.1136/bmj.g4198. View

13.

Ko J, Suh C, Huang H, Zhuo H, Harmanli O, Zhang Y . Association of Race/Ethnicity with Surgical Route and Perioperative Outcomes of Hysterectomy for Leiomyomas. J Minim Invasive Gynecol. 2020; 28(7):1403-1410.e2. DOI: 10.1016/j.jmig.2020.11.008. View

14.

Gadzinski A, Dimick J, Ye Z, Miller D . Utilization and outcomes of inpatient surgical care at critical access hospitals in the United States. JAMA Surg. 2013; 148(7):589-96. PMC: 3918670. DOI: 10.1001/jamasurg.2013.1224. View

15.

Papalekas E, Fisher J . Trends in Route of Hysterectomy after the Implementation of a Comprehensive Robotic Training Program. Minim Invasive Surg. 2018; 2018:7362489. PMC: 6166379. DOI: 10.1155/2018/7362489. View

16.

Su W, Coleman C, Bossick A, Lee-Griffith M, Wegienka G . Racial Differences in Planned Hysterectomy Procedure Route. J Womens Health (Larchmt). 2021; 31(1):31-37. DOI: 10.1089/jwh.2021.0132. View

17.

Sanei-Moghaddam A, Kang C, Edwards R, Lounder P, Ismail N, Goughnour S . Racial and Socioeconomic Disparities in Hysterectomy Route for Benign Conditions. J Racial Ethn Health Disparities. 2017; 5(4):758-765. DOI: 10.1007/s40615-017-0420-7. View

18.

. Committee Opinion No 701: Choosing the Route of Hysterectomy for Benign Disease. Obstet Gynecol. 2017; 129(6):e155-e159. DOI: 10.1097/AOG.0000000000002112. View

19.

Sanei-Moghaddam A, Ma T, Goughnour S, Edwards R, Lounder P, Ismail N . Changes in Hysterectomy Trends After the Implementation of a Clinical Pathway. Obstet Gynecol. 2015; 127(1):139-147. DOI: 10.1097/AOG.0000000000001185. View

20.

Moher D, Altman D, Liberati A, Tetzlaff J . PRISMA statement. Epidemiology. 2010; 22(1):128. DOI: 10.1097/EDE.0b013e3181fe7825. View